The reduction in price target by RBC Capital, from $10 to $8, suggests a bearish outlook on Clarivate's stock in the short term. This adjustment reflects the analyst's revised expectations on the company's future performance, potentially due to underlying challenges or slower growth prospects. As price targets are influential indicators for investors, this downward revision could lead to a negative sentiment among investors, likely causing a short-term decline in the stock price.